Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams

Author:

Vu H,Nikaido H

Abstract

Enterobacter cloacae strains producing chromosomally mediated beta-lactamase constitutively show high degrees of resistance to most of the third-generation beta-lactams. It has been proposed that this resistance is due to the nonhydrolytic binding or trapping of beta-lactams by the enzyme. We found that the outer membrane of E. cloacae strain 55M indeed had permeability to cefazolin about 14-fold lower than that of Escherichia coli, and that the number of beta-lactamase molecules produced by this constitutive mutant was exceptionally large (2 X 10(5) per cell). These conditions are expected to produce a low degree of resistance, but could not explain the high resistance level of the mutant. We showed that the beta-lactamase of this strain hydrolyzed third-generation beta-lactams at measurable rates. Although the V max for these compounds was less than 0.01% of that for cefazolin, the enzyme could hydrolyze them at rates comparable to the rate for cefazolin when the substrate concentration was near 0.1 microM, a concentration thought to be physiologically relevant for the inhibition of cell growth, because of the exceptionally high affinity of the enzyme to many third-generation compounds. Calculations based on kinetic parameters of the enzyme, outer membrane permeability, and affinity toward penicillin-binding proteins succeeded in predicting the MICs for several third-generation beta-lactams. The data suggest that hydrolysis may be more important than nonhydrolytic binding for the expression of the resistant phenotype, and that studies on the susceptibility of beta-lactams to beta-lactamases should be carried out at physiologically relevant, very low concentrations of the drug, rather than the customary very high concentrations, such as 100 microM.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference22 articles.

1. Interaction of azthreonam and related monobactams with 1-lactamases from gram-negative bacteria;Bush K.;Antimicrob. Agents Chemother.,1982

2. Concentration specifique reversible des amino acides chez Escherichia coli;Cohen G. N.;Ann. Inst. Pasteur (Paris),1956

3. Affinities of penicillins and cephalosporins for the penicillinbinding proteins of Escherichia coli K-12 and their antibacterial activity;Curtis N. A.;Antimicrob. Agents Chemother.,1979

4. Pole cap formation in Escherichia coli following induction of the maltose-binding protein;Dietzel I.;Arch. Microbiol.,1978

5. Resistance to cefamandole: derepression of beta-lactamase by cefoxitin and mutation in Enterobacter cloacae;Gootz T. D.;J. Infect. Dis.,1982

Cited by 201 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. AmpC Inhibition: An Explicit Approach against Multi-Drug Resistance (MDR);Current Topics in Medicinal Chemistry;2023-08-10

2. Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health;Science of The Total Environment;2023-02

3. The role of bioactive metabolites synthesized by endophytes against MDR human pathogens;Endophytic Association: What, Why and How;2023

4. Assessment of silver nanoparticle as anti-salmonella agent: Phenotypic and genotypic study;THE 2ND UNIVERSITAS LAMPUNG INTERNATIONAL CONFERENCE ON SCIENCE, TECHNOLOGY, AND ENVIRONMENT (ULICoSTE) 2021;2022

5. ANTIBIOTICOTERAPIA COM INIBIDORES β-LACTÂMICOS PARA RESSENSIBILIZAÇÃO DE BACTÉRIAS MULTIRRESISTENTES;Infarma - Ciências Farmacêuticas;2020-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3